Giulio Draetta

Active 1986–2025

119
Papers
29,544
Citations
85
h-index
114
i10-index

Citations

Citations per year for Giulio Draetta1975: 3 citations1987: 8 citations1988: 34 citations1989: 182 citations1990: 231 citations1991: 322 citations1992: 283 citations1993: 361 citations1994: 385 citations1995: 369 citations1996: 320 citations1997: 330 citations1998: 297 citations1999: 333 citations2000: 290 citations2001: 259 citations2002: 219 citations2003: 213 citations2004: 257 citations2005: 186 citations2006: 148 citations2007: 149 citations2008: 174 citations2009: 154 citations2010: 159 citations2011: 126 citations2012: 117 citations2013: 138 citations2014: 122 citations2015: 172 citations2016: 168 citations2017: 227 citations2018: 230 citations2019: 709 citations2020: 809 citations2021: 834 citations2022: 692 citations2023: 614 citations2024: 757 citations2025: 408 citations2026: 19 citations1976–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,668 citing papers, 36.4% of this breakdownChina: 1,446 citing papers, 11.3% of this breakdownUnited Kingdom: 761 citing papers, 5.9% of this breakdownGermany: 679 citing papers, 5.3% of this breakdownJapan: 553 citing papers, 4.3% of this breakdownItaly: 524 citing papers, 4.1% of this breakdownFrance: 479 citing papers, 3.7% of this breakdownCanada: 402 citing papers, 3.1% of this breakdownSpain: 238 citing papers, 1.9% of this breakdownSwitzerland: 229 citing papers, 1.8% of this breakdownAustralia: 227 citing papers, 1.8% of this breakdownIndia: 218 citing papers, 1.7% of this breakdown
0%36.4%Other 18.7%

Fields

  • Biochemistry, Genetics and Molecular Biology55.5%
  • Medicine34.6%
  • Immunology and Microbiology3.3%
  • Neuroscience2.8%
  • Agricultural and Biological Sciences1%
  • Engineering0.9%
  • Other1.9%

Topics

  • Cancer-related Molecular Pathways7.1%
  • Ubiquitin and proteasome pathways4.9%
  • Microtubule and mitosis dynamics4.5%
  • Cancer, Hypoxia, and Metabolism3.7%
  • Epigenetics and DNA Methylation3.4%
  • RNA modifications and cancer2.1%
  • Other74.3%

Coauthors

All papers

Open in search
  1. An inhibitor of oxidative phosphorylation exploits cancer vulnerability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lina Han, Verlene Henry, Judy Hirst, Sha Huang, Yongying Jiang, Zhijun Kang, Tin Oo Khor, Sergej Konoplev, Yu-Hsi Lin, Gang Liu, Alessia Lodi, Timothy Lofton, Helen Ma, Mikhila Mahendra, Polina Matre, Robert A. Mullinax, Michael Peoples, Alessia Petrocchi, Jaime Rodriguez-Canale, Riccardo Serreli, Thomas Shi, Melinda Smith, Yoko Tabe, Jay Theroff, Stefano Tiziani, Quanyun A. Xu, Qi Zhang, Florian L. Müller, Ronald A. DePinho, Carlo Toniatti, Giulio Draetta, Timothy P. Heffernan, Marina Konopleva, Philip Jones, Maria Emilia Di Francesco, Joseph R. Marszalek - Nature Medicine 2018 cited by 951

  2. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 1,273

  3. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2020 cited by 330

  4. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2014 cited by 735

  5. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Corry M. Jones, Mustafa Bdiwi, Ana Karen Nunez Cortes, Enli Liu, Jun Yu, Nobuhiko Imahashi, Luis Muniz-Feliciano, Ye Li, Jian Hu, Giulio Draetta, David Marín, Dihua Yu, Stephan Mielke, Matthias Eyrich, Richard E. Champlin, Ken Chen, Frederick F. Lang, Elizabeth J. Shpall, Amy B. Heimberger, Katayoun Rezvani - Journal of Clinical Investigation 2021 cited by 252

  6. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Carugo, Gioacchino Natoli, Andrea Viale - Science 2021 cited by 258

  7. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2015 cited by 270

  8. Genetics and biology of pancreatic ductal adenocarcinoma

    Authors: , , , , , , - Genes & Development 2016 cited by 536

  9. Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 157

  10. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Wang - Science Translational Medicine 2019 cited by 233

  11. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Carugo, Timothy P. Heffernan, Anirban Maitra, Andrea Viale, Haoqiang Ying, Samir Hanash, Ronald A. DePinho, Giulio Draetta - Nature 2019 cited by 215

  12. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 270

  13. Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meredith A. Miller, Pietro Morlacchi, Robert A. Mullinax, Wylie S. Palmer, Jihai Pang, Norma Rogers, Charles M. Rudin, Hannah E. Shepard, Nakia D. Spencer, Jay Theroff, Qi Wu, Alan Xu, Ju Anne Yau, Giulio Draetta, Carlo Toniatti, Timothy P. Heffernan, Philip Jones - Journal of Medicinal Chemistry 2020 cited by 91

  14. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair

    Authors: , , , , - Cell Reports 2016 cited by 313

  15. Tumors and Mitochondrial Respiration: A Neglected Connection

    Authors: , , - Cancer Research 2015 cited by 259

  16. SCF Fbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins

    Authors: , , , , , , , - Science 2007 cited by 508

  17. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 149

  18. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anirban Maitra, Maria Emilia Di Francesco, Timothy A. Yap, Philip Jones, Giulio Draetta, Alessandro Carugo, Frédéric Chédin, Timothy P. Heffernan - Nature Communications 2021 cited by 78

  19. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 60

  20. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 163

  21. Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meredith A. Miller, Robert A. Mullinax, Michael Peoples, Vandhana Ramamoorthy, Sahil Seth, Nakia D. Spencer, Érika Suzuki, Christopher C. Williams, Simon S. Yu, Andy M. Zuniga, Giulio Draetta, Joseph R. Marszalek, Timothy P. Heffernan, Nancy E. Kohl, Philip Jones - Cancer Research 2020 cited by 106

  22. Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 48

  23. Cyclin A is required at two points in the human cell cycle.

    Authors: , , , , - The EMBO Journal 1992 cited by 1,408

  24. Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

    Authors: , , , , - Genes & Development 1993 cited by 1,633